PANS

Clinical trial pipeline · Data from ClinicalTrials.gov

See which PANS trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingNot Applicable

NCT06811935

PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects…

United States30 participantsStarted 2025-02-17

RecruitingNot Applicable

NCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle in…

United States10,000 participantsStarted 2023-07-05

RecruitingNot Applicable

NCT02889016

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a co…

United States500 participantsStarted 2013-03

All recent trials (12 shown)

CompletedPhase 2

NCT04609761

Open-label Trial of IVIG in Children With PANS

Open-label prospective trial to study efficacy, safety and tolerability of intravenous immunoglobulin (IVIG) once monthly for 6 months in children and adolescen…

Sweden17 participantsStarted 2021-01-12

Treatment: Privigen Injectable Product (Intravenous Immunoglobulin)

CompletedPhase 3

NCT04508530

Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric…

A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome

United States71 participantsStarted 2021-06-30

Treatment: Panzyga, Placebo

PANS

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

All recent trials (12 shown)

Open-label Trial of IVIG in Children With PANS

Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric…

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

All recent trials (12 shown)

Open-label Trial of IVIG in Children With PANS

Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric…

The Unhide™ Project: Economic Impact Study of IVIG Treatment for PANS

Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset…

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Antibiotic Treatment Trial for the PANDAS/PANS Phenotype